WBAWalgreens Boots Alliance, Inc.

Nasdaq walgreensbootsalliance.com


$ 12.18 $ -3.47 (-22.16 %)    

Thursday, 27-Jun-2024 15:59:56 EDT
QQQ $ 482.07 $ 1.24 (0.26 %)
DIA $ 391.62 $ 0.32 (0.08 %)
SPY $ 546.37 $ 0.86 (0.16 %)
TLT $ 93.57 $ 0.37 (0.4 %)
GLD $ 215.08 $ 2.41 (1.13 %)
$ 12.19
$ 13.29
$ 0.00 x 0
$ 12.21 x 100
$ 11.69 - $ 13.31
$ 11.68 - $ 29.30
131,996,794
na
10.51B
$ 0.75
nm
TBD
na
na ($ 0.12)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 06-27-2024 05-31-2024 10-Q
2 03-28-2024 02-29-2024 10-Q
3 01-04-2024 11-30-2023 10-Q
4 10-12-2023 08-31-2023 10-K
5 06-27-2023 05-31-2023 10-Q
6 03-28-2023 02-28-2023 10-Q
7 01-05-2023 11-30-2022 10-Q
8 10-13-2022 08-31-2022 10-K
9 06-30-2022 05-31-2022 10-Q
10 03-31-2022 02-28-2022 10-Q
11 01-06-2022 11-30-2021 10-Q
12 10-14-2021 08-31-2021 10-K
13 07-01-2021 05-31-2021 10-Q
14 03-31-2021 02-28-2021 10-Q
15 01-07-2021 11-30-2020 10-Q
16 10-15-2020 08-31-2020 10-K
17 07-09-2020 05-31-2020 10-Q
18 04-02-2020 02-29-2020 10-Q
19 01-08-2020 11-30-2019 10-Q
20 10-28-2019 08-31-2019 10-K
21 06-27-2019 05-31-2019 10-Q
22 04-02-2019 02-28-2019 10-Q
23 12-20-2018 11-30-2018 10-Q
24 10-11-2018 08-31-2018 10-K
25 06-28-2018 05-31-2018 10-Q
26 03-28-2018 02-28-2018 10-Q
27 01-04-2018 11-30-2017 10-Q
28 10-25-2017 08-31-2017 10-K
29 06-29-2017 05-31-2017 10-Q
30 04-05-2017 02-28-2017 10-Q
31 01-05-2017 11-30-2016 10-Q
32 10-20-2016 08-31-2016 10-K
33 07-06-2016 05-31-2016 10-Q
34 04-05-2016 02-29-2016 10-Q
35 01-07-2016 11-30-2015 10-Q
36 10-28-2015 08-31-2015 10-K
37 07-09-2015 05-31-2015 10-Q
38 04-09-2015 02-28-2015 10-Q
39 12-30-2014 11-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 walgreens-via-transformational-cost-management-program-plans-to-reduce-presence-by-up-to-650-boots-stores-in-uk-and-about-650-to-700-stores-in-us

-SEC Filing

 stocks-show-modest-gains-ahead-of-feds-inflation-report-chipmakers-struggle-while-gold-and-bitcoin-rebound-whats-driving-markets-thursday

Wall Street experienced a subdued trading day on Thursday, as traders likely chose to remain on the sidelines in anticipation o...

 walgreens-plans-significant-store-closures-as-it-faces-difficult-operating-environment

Major US pharma chain Walgreens to close undisclosed number of stores due to headwinds, CEO acknowledges challenges. Rite Aid a...

 stock-of-the-day-its-no-coincidence-cvs-health-stock-found-support-where-it-did

It isn't a coincidence that shares of CVS Health Corporation (CVS) found support where they did. It was at a former resista...

Core News & Articles

NVDAMUTSLAHIMSBBAIRIVNAAPLWAYWBAData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

 walgreens-ceo-says-additional-store-closures-will-be-contemplated-if-performance-does-not-improve

- Conference Call

 walgreens-exec-says-current-pharmacy-model-is-unsustainable-and-challenges-require-a-new-market-approach

- Conference Call

 us-retail-pharma-giant-walgreens-boots-alliance-q3-earnings-and-annual-outlook-disappoints-stock-sinks

Walgreens Boots Alliance's Q3 FY2024 sales increased 2.6% to $36.35 billion, surpassing the $36 billion consensus. Adjusted...

 wall-street-set-for-weak-opening-as-tech-rally-falters-with-micron-nvidia-edging-lower-analyst-says-narrow-market-performance-to-persists-unless-one-of-these-materializes

The two-day rally the broader market witnessed could stall, as traders choose to remain cautious ahead of a string of economic ...

 nike-micron-and-3-stocks-to-watch-heading-into-thursday

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as fo...

 kkrs-johannes-huth-retires-after-pioneering-european-deals---details-here

Johannes Huth, pivotal figure in KKR's European ventures, retires after 25 years, leaving legacy of strategic acquisitions ...

 judge-rules-against-medimpact-in-200m-rite-aid-debt-dispute

MedImpact's bid to reclaim $200 million after acquiring Rite Aid's pharmacy benefits unit has failed. U.S. Bankruptcy J...

 ubs-maintains-neutral-on-walgreens-boots-alliance-lowers-price-target-to-17

UBS analyst Kevin Caliendo maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Neutral and lowers the price target from $...

 barclays-maintains-underweight-on-walgreens-boots-alliance-lowers-price-target-to-19

Barclays analyst Steve Valiquette maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Underweight and lowers the price ta...